Terms: = Prostate cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Staging
14 results:
1. PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review.
Petersen LJ; Zacho HD
Cancer Imaging; 2020 Jan; 20(1):10. PubMed ID: 31973751
[TBL] [Abstract] [Full Text] [Related]
2. High-intensity Focused Ultrasound for the Treatment of prostate cancer: A National Cohort Study Focusing on the Development of Stricture and Fistulae.
Dosanjh A; Harvey P; Baldwin S; Mintz H; Evison F; Gallier S; Trudgill N; James ND; Sooriakumaran P; Patel P
Eur Urol Focus; 2021 Mar; 7(2):340-346. PubMed ID: 31924529
[TBL] [Abstract] [Full Text] [Related]
3. Outcomes of Primary Lymph Node staging of Intermediate and High Risk prostate cancer with
Yaxley JW; Raveenthiran S; Nouhaud FX; Samartunga H; Yaxley AJ; Coughlin G; Delahunt B; Egevad L; McEwan L; Wong D
J Urol; 2019 Apr; 201(4):815-820. PubMed ID: 30672842
[TBL] [Abstract] [Full Text] [Related]
4. Utility of early transperineal template-guided prostate biopsy for risk stratification in men undergoing active surveillance for prostate cancer.
Voss J; Pal R; Ahmed S; Hannah M; Jaulim A; Walton T
BJU Int; 2018 Jun; 121(6):863-870. PubMed ID: 29239082
[TBL] [Abstract] [Full Text] [Related]
5. Bone Scan Index Is an Independent Predictor of Time to Castration-resistant prostate cancer in Newly Diagnosed prostate cancer: A Prospective Study.
Zacho HD; Gade M; Mortensen JC; Bertelsen H; Boldsen SK; Barsi T; Petersen LJ
Urology; 2017 Oct; 108():135-141. PubMed ID: 28760556
[TBL] [Abstract] [Full Text] [Related]
6. Outcome of radical prostatectomy as primary treatment for high-risk prostate cancer patients.
Kulkarni JN; Gunavanthe VS; Dhale A
Indian J Cancer; 2015; 52(4):646-52. PubMed ID: 26960506
[TBL] [Abstract] [Full Text] [Related]
7. Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized prostate cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial.
Blanchard P; Faivre L; Lesaunier F; Salem N; Mesgouez-Nebout N; Deniau-Alexandre E; Rolland F; Ferrero JM; Houédé N; Mourey L; Théodore C; Krakowski I; Berdah JF; Baciuchka M; Laguerre B; Davin JL; Habibian M; Culine S; Laplanche A; Fizazi K
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):85-92. PubMed ID: 26576711
[TBL] [Abstract] [Full Text] [Related]
8. [The criteria for avoiding unnecessary computerized tomography and bone scan in staging patients with newly diagnosed prostate cancer: retrospective study of patients at Matsusaka Chuo General Hospital].
Matsumura Y; Otani T; Yoneda T; Matsumoto Y; Maruyama Y; Fujimoto K; Hirao Y
Nihon Hinyokika Gakkai Zasshi; 2007 Sep; 98(6):764-9. PubMed ID: 17929458
[TBL] [Abstract] [Full Text] [Related]
9. Computer technology in detection and staging of prostate carcinoma: a review.
Zhu Y; Williams S; Zwiggelaar R
Med Image Anal; 2006 Apr; 10(2):178-99. PubMed ID: 16150630
[TBL] [Abstract] [Full Text] [Related]
10. Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen.
Krahn MD; Coombs A; Levy IG
CMAJ; 1999 Jan; 160(1):49-57. PubMed ID: 9934343
[TBL] [Abstract] [Full Text] [Related]
11. The value of the ratio of free-to-total prostate specific antigen for staging purposes in previously untreated prostate cancer.
Noldus J; Graefen M; Huland E; Busch C; Hammerer P; Huland H
J Urol; 1998 Jun; 159(6):2004-7; discussion 2007-8. PubMed ID: 9598507
[TBL] [Abstract] [Full Text] [Related]
12. The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program.
Smart CR
Cancer; 1997 Nov; 80(9):1835-44. PubMed ID: 9351557
[TBL] [Abstract] [Full Text] [Related]
13. Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy.
Borirakchanyavat S; Bhargava V; Shinohara K; Toke A; Carroll PR; Presti JC
Urology; 1997 Sep; 50(3):373-8. PubMed ID: 9301700
[TBL] [Abstract] [Full Text] [Related]
14. Lymphangiography in staging of carcinoma of the prostate: the potential value of percutaneous lymph node biopsy.
Prando A; Wallace S; Von Eschenbach AC; Jing BS; Rosengren JE; Hussey DH
Radiology; 1979 Jun; 131(3):641-5. PubMed ID: 441369
[TBL] [Abstract] [Full Text] [Related]
